Navigation Links
Genaera Corporation to Present at BIO Business Forum
Date:6/12/2008

ning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties, known and unknown. Forward-looking statements reflect management's current views and are based on certain expectations and assumptions. Such statements include, among others, statements regarding the preliminary results, clinical development plans and prospects for Genaera's programs including trodusquemine (MSI-1436) and the IL-9 antibody program. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "believe," "continue," "develop," "expect," "plan" and "potential" or other words of similar meaning. Genaera's actual results and performance could differ materially from those currently anticipated and expressed in these and other forward-looking statements as a result of a number of risk factors, including, but not limited to: Genaera's history of operating losses since inception and its need for additional funds to operate its business; the costs, delays and uncertainties inherent in scientific research, drug development, clinical trials and the regulatory approval process; the risk that clinical trials for Genaera's product candidates including trodusquemine (MSI-1436) and the IL-9 antibody program may be delayed or may not be successful; the risk that Genaera may not obtain regulatory approval for its products, whether due to adequacy of the development program, the conduct of the clinical trials, changing regulatory requirements, different methods of evaluating and interpreting data, regulatory interpretations of clinical risk and benefit, or otherwise; Genaera's reliance on its collaborator, in connection with the development and commercialization of Genaera's IL-9 antibody program; market acceptance of Genaera's products, if regulatory approval is achieved; competition; general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industry; and
'/>"/>
SOURCE Genaera Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Genaera Corporation Announces First Quarter Financial Results
2. Genaera Corporation Announces 2007 Financial Results
3. Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference
4. Genaera Corporation Announces Third Quarter Financial Results
5. Genaera to Present at Biotech 2007 and BIO InvestorForum
6. Genaera Elects New Board Member and Announces Executive Appointments
7. Met-Pro Corporations Fybroc Business Unit Receives Equipment Order Totaling Approximately $500,000
8. Veridex Announces Agreement to Acquire the Assets of Immunicon Corporation
9. Environmental Tectonics Corporations BioMedical Systems Division Awarded Contract for Multiple Monoplace Chambers
10. BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
11. DURECT Corporation to Participate in Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... zFlo Motion , a US leader ... exciting product from a new partner. STT-Systems has ... past 15 years, with offerings in the optical-motion capture, 3D ... system (inertial measurement unit), iSen, is opening eyes around the ...
(Date:1/22/2015)... Selexis SA, a serial innovation company ... (RCBs) used for drug discovery to commercial manufacturing, announced ... Next-Generation Sequencing (NGS) data packages. The NGS ... by ensuring the integrity of the gene, validation of ...
(Date:1/22/2015)... DIEGO , Jan. 22, 2015   Cypher ... and Sequenom, Inc. (NASDAQ: SQNM ), ... development agreement for next generation noninvasive prenatal tests ... genome interpretation technology, called Mantis™, to advance analysis ...
(Date:1/22/2015)... , Jan. 22, 2015  Derma Sciences, Inc. (Nasdaq: ... focused on advanced wound care, announces that AMNIOEXCEL® ... have been added to the Premier, Inc. Regenerative ... opportunity for the AMNIOEXCEL® and AMNIOMATRIX® product lines, ...
Breaking Biology Technology:3D Motion Capture Just Got Easy 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5
... ViroPharma Incorporated (Nasdaq: VPHM ) today announced that ... investment conferences. , Vincent Milano, president and chief ... 20th Annual Healthcare Conference at 4:30 P.M. EST on ... held at the Waldorf=Astoria in New York City. , ...
... 50/50 joint venture agreement signed with Hunan, Biopharmaceutical ... manufacturing facility, - Biologics: 23% growth in sales and to ... of KINLYTIC(TM) thrombolytic, agent for pulmonary embolism, ... under, agreement, - Dr. Mark ...
... DNDN ) today announced that management will present at the following upcoming ... New York City, Tuesday, November 10, 2009, ... Phoenix, Arizona, Friday, November 13, 2009, ... Conference, New York City, Tuesday, November 17, ...
Cached Biology Technology:ViroPharma to Present at Three November Healthcare Conferences 2Microbix Biosystems Provides a Corporate Update 2Microbix Biosystems Provides a Corporate Update 3Microbix Biosystems Provides a Corporate Update 4Microbix Biosystems Provides a Corporate Update 5Microbix Biosystems Provides a Corporate Update 6Microbix Biosystems Provides a Corporate Update 7
(Date:12/19/2014)... Calif. , Dec. 18, 2014  23andMe, Inc., the leading ... that pinpoints fine-scale differences in genetic ancestry of individuals from ... Since immigrants first arrived more than four hundred years ago, ... a meeting place for peoples from different continents. This study ...
(Date:12/17/2014)... DUBLIN , Dec. 15, 2014 Research and Markets ... of the "Samsung Galaxy S5 - Home Button ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... the iPhone 5S, Samsung introduces for the first time ...
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB SM ... (GCP) audit to confirm its adherence to current U.S. ... HITLAB to conduct regulated smart device and smart phone ... and research quality. "HITLAB is determined to ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... mythological beliefs. Some cultures prize them for their supposed ... dagger handles or good luck charms. But new research ... explaining how the horn gets its distinctive curve and ... about the structural materials that form the horn and ...
... an organism invest energy in a few large offspring ... The American Naturalist, Michael Angilletta (Indiana State University), Chris ... of California, Berkeley) used a new statistical approach that ... approach they hope will shed light on many evolutionary ...
... California, San Diego biologists shows that invasive Argentine ants ... foe, a finding that helps to explain why these ... In the December issue of the journal Molecular Ecology, ... among Argentine ants in the field. In California, ...
Cached Biology News:Scientists crack rhino horn riddle 2Invasive ants territorial when neighbors are not kin 2Invasive ants territorial when neighbors are not kin 3
8 different frozen tissues are mounted on positively charged glass slides...
... Kit is optimized for the ... of ready-to-use dsRNA for RNAi ... MEGAscript RNAi Kit is based ... technol-ogy and includes reagents for ...
...
... VSO LF (Low Flow) offers the same benefits ... for applications where control is critical or flow ... valve automates the flow of gas in proportion ... DC current or pulse width modulation; closed loop ...
Biology Products: